Herbert Timothy P.'s Form 4 filing
Inspire Medical Systems, Inc. (INSP) · filed Mar 13, 2023
- Accession no.
- 0001104659-23-031810
- Filed
- Mar 13, 2023
- Trade date
- Apr 22, 2019-Feb 15, 2023
- Filing delay
- 1,421 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 24 non-derivative transactions. Open-market sales total $8.77M. It was filed 1421 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Herbert Timothy P.CIK 0001737136 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 22, 2019 | Common Stock | GGiftDisposed | −238 | $0.00 | $0 | 9,850 | Indirect | |
| Apr 22, 2019 | Common Stock | GGiftAcquired | +238 | $0.00 | $0 | 113,373 | Indirect | |
| Mar 17, 2020 | Common Stock | GGiftDisposed | −9,649 | $0.00 | $0 | 150,402 | Direct | |
| Mar 17, 2020 | Common Stock | GGiftAcquired | +9,649 | $0.00 | $0 | 9,629 | Indirect | |
| Mar 17, 2020 | Common Stock | GGiftDisposed | −27,735 | $0.00 | $0 | 85,638 | Indirect | |
| Mar 17, 2020 | Common Stock | GGiftAcquired | +27,735 | $0.00 | $0 | 27,735 | Indirect | |
| Dec 23, 2020 | Common Stock | GGiftDisposed | −85,638 | $0.00 | $0 | 0 | Indirect | |
| Dec 23, 2020 | Common Stock | GGiftAcquired | +20,717 | $0.00 | $0 | 171,119 | Direct | |
| Dec 23, 2020 | Common Stock | GGiftAcquired | +64,921 | $0.00 | $0 | 92,656 | Indirect | |
| Nov 20, 2021 | Common Stock | GGiftDisposed | −8,420 | $0.00 | $0 | 1,229 | Indirect | |
| Nov 20, 2021 | Common Stock | GGiftAcquired | +8,420 | $0.00 | $0 | 179,539 | Direct | |
| Jan 24, 2022 | Common Stock | GGiftDisposed | −25,000 | $0.00 | $0 | 154,539 | Direct | |
| Jan 24, 2022 | Common Stock | GGiftAcquired | +25,000 | $0.00 | $0 | 34,850 | Indirect | |
| Jan 27, 2022 | Common Stock | GGiftDisposed | −29,976 | $0.00 | $0 | 124,563 | Direct | |
| Jan 27, 2022 | Common Stock | GGiftAcquired | +14,892 | $0.00 | $0 | 49,742 | Indirect | |
| Jan 27, 2022 | Common Stock | GGiftAcquired | +15,084 | $0.00 | $0 | 107,740 | Indirect | |
| Oct 11, 2022 | Common Stock | GGiftDisposed | −35,117 | $0.00 | $0 | 89,446 | Direct | |
| Oct 11, 2022 | Common Stock | GGiftAcquired | +35,117 | $0.00 | $0 | 36,346 | Indirect | |
| Nov 21, 2022 | Common Stock | GGiftDisposed | −36,346 | $0.00 | $0 | 0 | Indirect | |
| Nov 21, 2022 | Common Stock | GGiftAcquired | +12,231 | $0.00 | $0 | 119,971 | Indirect | |
| Nov 21, 2022 | Common Stock | GGiftAcquired | +24,115 | $0.00 | $0 | 113,561 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −18,642 | $275.47F10 | −$5,135,311.74 | 31,100 | Indirect | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −1,496 | $276.18F11 | −$413,165.28 | 29,604 | Indirect | |
| Feb 15, 2023 | Common Stock | SSaleDisposed | −11,715 | $275.17F12 | −$3,223,616.55 | 17,889 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.00 to $275.96, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F11
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.00 to $276.43, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F12
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.00 to $275.94, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.